MHRP's African Cohort Study, or AFRICOS, represents the intersection of research and global health programming to bring about an end to HIV. At the AIDS 2024 conference, researchers shared a wealth of data and findings from the AFRICOS study on topics ranging from the neurocognitive effects of HIV in young people, to food insecurity among PEPFAR clients, to hypertension and cardiovascular health in people living with HIV, and more. Congratulations to the presenters and collaborators sharing their important work with the world at AIDS 2024:
Oral Presentations:
- Romo ML, Frndak S, Dear N, Kibuuka H, Owuoth J, Sing’oei V, Maswai J, Bahemana E, Anyebe V, Parker Z, Cavanaugh JS, Shah N, Ake JA, Crowell TA, on behalf of the AFRICOS study group. Dolutegravir-containing antiretroviral therapy and incident hypertension: Findings from a prospective cohort in Kenya, Nigeria, Tanzania, and Uganda. IAS. 2024. Accepted, Oral Presentation.
- Frndak S, Tsoy E, Dear N, Kibuuka H, Owuoth J, Sing’oei V, Maswai J, Bahemana E, Anyebe V, Parker Z, Cavanaugh JS, Shah N, Crowell TA, Ake JA, Valcour V, on behalf of the AFRICOS study group. Food Insecurity and HIV status on cognitive trajectories. IAS. 2024. Accepted, Oral Presentation.
Poster Presentation:
- Chachage M, Parikh AP, Mahenge A, Bahemana E, Mnkai J, Sudi L, Mcharo R, Maganga L, Ntinginya N, Mwamwaja J, Gervas R, Kibuuka H, Maswai J, Singoei V, Anyebe V, Parker Z, Dear N, Imbach M, Crowell TA, Hern J, Bartolanzo D, Kroidl A, Kroidl I, Hoelscher M, Shah N, Ake JA, Geldmacher C, on behalf of the AFRICOS study group. High-risk human papillomavirus persistence and incidence among women living with HIV in the African Cohort Study. IAS. 2024. Accepted, Poster.
AFRICOS is a long-term prospective cohort study at sites in four African countries that evaluates HIV prevention, care and treatment services implemented through local facilities, funded by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR).
